AMN Healthcare Services, Inc.
NYSE:AMNMedical - Care Facilities
-$1.29 today
- Market cap
- $1.45B
- Beta
- 0.44
- P/E (TTM)
- -37.3
- EPS (TTM)
- -$0.83
Volume 0.55M
Average 1.02M
AMN EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
AMN Healthcare Services, Inc.NYSE: AMN
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA grows, but more slowly than its trailing trend
Q1 FY2026 EBITDA of $152.83M rose 191.9% year over year, behind the +416.8% change in trailing-twelve-month EBITDA. Sequentially, it rose 237.0% from the prior quarter. Over 3 fiscal years it compounded at -49.5% a year.
Context
- EBITDA amounted to 3.7% of revenue in FY2025, up 1.3 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of $402.07M (+297.6%) for the fiscal year ending Dec 2026, a step up from the +42.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $152.83M+237.0% QoQ
- Last fiscal yearDec 2025
- $101.13M+42.2% YoY
- LTMMar 2026
- $201.6M+416.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +191.9% | +160.3% | -31.5 pp |
| 1 year | +42.2% | +297.6% | +255.4 pp |
| 3-year CAGR | -49.5% | +31.7% | +81.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 101.13M USD
- Year-over-year change
- +42.2%
- 4-year CAGR
- -35.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 101.13M | +42.2% |
| FY2024 | 2024-12-31 | 71.11M | -85.8% |
| FY2023 | 2023-12-31 | 499.36M | -36.3% |
| FY2022 | 2022-12-31 | 784.21M | +34.8% |
| FY2021 | 2021-12-31 | 581.7M | — |
EBITDA vs competitors
How AMN compares with its peers on the latest reported figures
- AMN's LTM Mar 2026 EBITDA of $201.6M is the 2nd highest of the 11 companies compared; the peer median is -$121.66M.
- Its year-over-year change of +416.8% is the highest of 11, against a peer median of -9.0%.
- EBITDA amounts to 5.9% of revenue for AMN, versus a peer median of 29.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $291.89M | +36.3% | — | 33.2% | |
| LTM Mar 2026 | $201.6M | +416.8% | -49.5% | 5.9% | |
| LTM Mar 2026 | $69.88M | +7.2% | +7.6% | 22.4% | |
| LTM Mar 2026 | $4.32M | +307.7% | -35.7% | 2.8% | |
| LTM Jun 2026 | -$55.57M | +77.9% | — | 26.6% | |
| LTM Mar 2026 | -$66.72M | -25.2% | — | 64.8% | |
| LTM Mar 2026 | -$176.6M | -34.4% | — | — | |
| LTM Mar 2026 | -$210.87M | +45.6% | — | 149.2% | |
| LTM Dec 2025 | -$311.38M | -33.2% | — | — | |
| LTM Mar 2026 | -$314.51M | -1056.6% | — | 16.7% | |
| LTM Mar 2026 | -$334.2M | -423.0% | — | 40.3% | |
| Peer median (excluding AMN) | -$121.66M | -9.0% | -14.1% | 29.9% | |
Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.98B | 5.24B | 3.79B | 2.98B | 2.73B |
| Cost of Revenue | 2.67B | 3.53B | 2.54B | 2.06B | 1.96B |
| Gross Profit | 1.31B | 1.72B | 1.25B | 919.38M | 774.06M |
| Gross Margin | 32.9% | 32.7% | 33.0% | 30.8% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 730.45M | 936.58M | 756.24M | 632.49M | 593.02M |
| Operating Expenses | 831.6M | 1.07B | 911.15M | 1.02B | 740.89M |
| Depreciation & Amortization | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M |
| EBITDA | 581.7M | 784.21M | 499.36M | 71.11M | 101.13M |
| EBITDA Margin | 14.6% | 15.0% | 13.2% | 2.4% | 3.7% |
| Operating Income | 478M | 647.1M | 338.43M | (102.67M) | 33.17M |
| Operating Margin | 12.0% | 12.3% | 8.9% | -3.4% | 1.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.08M | 40.4M | 54.14M | 69.9M | 45.59M |
| Other Income / Expenses | (34.08M) | (40.4M) | (54.14M) | (69.9M) | (134.23M) |
| Income Before Tax | 443.92M | 606.7M | 284.29M | (172.57M) | (101.06M) |
| Pre-Tax Margin | 11.1% | 11.6% | 7.5% | -5.8% | -3.7% |
| Income Tax Expense | 116.53M | 162.65M | 73.61M | (25.6M) | (5.36M) |
| Net Income | 327.39M | 444.05M | 210.68M | (146.98M) | (95.7M) |
| Net Margin | 8.2% | 8.5% | 5.6% | -4.9% | -3.5% |
| EPS (Basic) | 6.87 | 9.96 | 5.38 | (3.85) | (2.48) |
| EPS (Diluted) | 6.81 | 9.90 | 5.36 | (3.85) | (2.48) |
| Weighted Avg Shares | 47.69M | 44.59M | 39.17M | 38.19M | 38.52M |
| Weighted Avg Shares (Diluted) | 48.05M | 44.87M | 39.34M | 38.19M | 38.52M |
AMN Healthcare Services, Inc.
NYSE:AMN
Intrinsic Alpha fair value
Locked
Current Price
$37.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.